These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

393 related items for PubMed ID: 7928489

  • 1. National Cancer Institute (phase II) study of high-grade glioma treated with accelerated hyperfractionated radiation and iododeoxyuridine: results in anaplastic astrocytoma.
    Sullivan FJ, Herscher LL, Cook JA, Smith J, Steinberg SM, Epstein AH, Oldfield EH, Goffman TE, Kinsella TJ, Mitchell JB.
    Int J Radiat Oncol Biol Phys; 1994 Oct 15; 30(3):583-90. PubMed ID: 7928489
    [Abstract] [Full Text] [Related]

  • 2. Long-term follow-up on National Cancer Institute Phase I/II study of glioblastoma multiforme treated with iododeoxyuridine and hyperfractionated irradiation.
    Goffman TE, Dachowski LJ, Bobo H, Oldfield EH, Steinberg SM, Cook J, Mitchell JB, Katz D, Smith R, Glatstein E.
    J Clin Oncol; 1992 Feb 15; 10(2):264-8. PubMed ID: 1310102
    [Abstract] [Full Text] [Related]

  • 3. Pharmacology and phase I/II study of continuous intravenous infusions of iododeoxyuridine and hyperfractionated radiotherapy in patients with glioblastoma multiforme.
    Kinsella TJ, Collins J, Rowland J, Klecker R, Wright D, Katz D, Steinberg SM, Glastein E.
    J Clin Oncol; 1988 May 15; 6(5):871-9. PubMed ID: 2835444
    [Abstract] [Full Text] [Related]

  • 4. Iododeoxyuridine (IUdR) combined with radiation in the treatment of malignant glioma: a comparison of short versus long intravenous dose schedules (RTOG 86-12).
    Urtasun RC, Cosmatos D, DelRowe J, Kinsella TJ, Lester S, Wasserman T, Fulton DS.
    Int J Radiat Oncol Biol Phys; 1993 Sep 30; 27(2):207-14. PubMed ID: 8407393
    [Abstract] [Full Text] [Related]

  • 5. Treatment of locally advanced cancer of the head and neck with 5'-iododeoxyuridine and hyperfractionated radiation therapy: measurement of cell labeling and thymidine replacement.
    Epstein AH, Lebovics RS, Goffman T, Teague D, Fuetsch ES, Glatstein E, Okunieff P, Cook JA.
    J Natl Cancer Inst; 1994 Dec 07; 86(23):1775-80. PubMed ID: 7966416
    [Abstract] [Full Text] [Related]

  • 6. Hyperfractionated radiation therapy and bis-chlorethyl nitrosourea in the treatment of malignant glioma--possible advantage observed at 72.0 Gy in 1.2 Gy B.I.D. fractions: report of the Radiation Therapy Oncology Group Protocol 8302.
    Nelson DF, Curran WJ, Scott C, Nelson JS, Weinstein AS, Ahmad K, Constine LS, Murray K, Powlis WD, Mohiuddin M.
    Int J Radiat Oncol Biol Phys; 1993 Jan 15; 25(2):193-207. PubMed ID: 8380567
    [Abstract] [Full Text] [Related]

  • 7. Hyperfractionated radiation therapy (HFX RT) followed by multiagent chemotherapy (CHT) in patients with malignant glioma: a phase II study.
    Jeremic B, Grujicic D, Antunovic V, Djuric L, Stojanovic M, Shibamoto Y.
    Int J Radiat Oncol Biol Phys; 1994 Dec 01; 30(5):1179-85. PubMed ID: 7961028
    [Abstract] [Full Text] [Related]

  • 8. Continuous 28-day iododeoxyuridine infusion and hyperfractionated accelerated radiotherapy for malignant glioma: a phase I clinical study.
    Schulz CA, Mehta MP, Badie B, McGinn CJ, Robins HI, Hayes L, Chappell R, Volkman J, Binger K, Arzoomanian R, Simon K, Alberti D, Feierabend C, Tutsch KD, Kunugi KA, Wilding G, Kinsella TJ.
    Int J Radiat Oncol Biol Phys; 2004 Jul 15; 59(4):1107-15. PubMed ID: 15234045
    [Abstract] [Full Text] [Related]

  • 9. Survival results from a phase I study of etanidazole (SR2508) and radiotherapy in patients with malignant glioma.
    Chang EL, Loeffler JS, Riese NE, Wen PY, Alexander E, Black PM, Coleman CN.
    Int J Radiat Oncol Biol Phys; 1998 Jan 01; 40(1):65-70. PubMed ID: 9422559
    [Abstract] [Full Text] [Related]

  • 10. Final report of a phase I/II trial of hyperfractionated and accelerated hyperfractionated radiation therapy with carmustine for adults with supratentorial malignant gliomas. Radiation Therapy Oncology Group Study 83-02.
    Werner-Wasik M, Scott CB, Nelson DF, Gaspar LE, Murray KJ, Fischbach JA, Nelson JS, Weinstein AS, Curran WJ.
    Cancer; 1996 Apr 15; 77(8):1535-43. PubMed ID: 8608540
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Halogenated pyrimidines as radiosensitizers in the treatment of glioblastoma multiforme.
    Jackson D, Kinsella T, Rowland J, Wright D, Katz D, Main D, Collins J, Kornblith P, Glatstein E.
    Am J Clin Oncol; 1987 Oct 15; 10(5):437-43. PubMed ID: 2821790
    [Abstract] [Full Text] [Related]

  • 15. Concurrent accelerated hyperfractionated radiation therapy and carboplatin/etoposide in patients with malignant glioma: long-term results of a phase II study.
    Jeremic B, Shibamoto Y, Grujicic D, Stojanovic M, Milicic B, Nikolic N, Dagovic A, Aleksandrovic J.
    J Neurooncol; 2001 Jan 15; 51(2):133-41. PubMed ID: 11386410
    [Abstract] [Full Text] [Related]

  • 16. Development of anaplastic changes in low-grade astrocytomas of childhood.
    Dirks PB, Jay V, Becker LE, Drake JM, Humphreys RP, Hoffman HJ, Rutka JT.
    Neurosurgery; 1994 Jan 15; 34(1):68-78. PubMed ID: 8121571
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Phase III trial of accelerated hyperfractionation with or without difluromethylornithine (DFMO) versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme.
    Prados MD, Wara WM, Sneed PK, McDermott M, Chang SM, Rabbitt J, Page M, Malec M, Davis RL, Gutin PH, Lamborn K, Wilson CB, Phillips TL, Larson DA.
    Int J Radiat Oncol Biol Phys; 2001 Jan 01; 49(1):71-7. PubMed ID: 11163499
    [Abstract] [Full Text] [Related]

  • 19. Long-term outcome of patients with WHO Grade III and IV gliomas treated by fractionated intracavitary radioimmunotherapy.
    Reulen HJ, Poepperl G, Goetz C, Gildehaus FJ, Schmidt M, Tatsch K, Pietsch T, Kraus T, Rachinger W.
    J Neurosurg; 2015 Sep 01; 123(3):760-70. PubMed ID: 26140493
    [Abstract] [Full Text] [Related]

  • 20. Survival improvement in anaplastic astrocytoma, combining external radiation with halogenated pyrimidines: final report of RTOG 86-12, Phase I-II study.
    Urtasun RC, Kinsella TJ, Farnan N, DelRowe JD, Lester SG, Fulton DS.
    Int J Radiat Oncol Biol Phys; 1996 Dec 01; 36(5):1163-7. PubMed ID: 8985039
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.